Filtered By:
Education: Lessons

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 553 results found since Jan 2013.

Applications for oral research in microgravity - lessons learned from burning mouth syndrome and ageing studies
J Med Life. 2023 Mar;16(3):381-386. doi: 10.25122/jml-2022-0285.ABSTRACTThe negative consequences of microgravity for the human body are central aspects of space travel that raise health problems. Altered functions of the same systems and treatment options are common points of spaceflight physiology, age-related diseases, and oral medicine. This work emphasizes the convergence of knowledge between pathophysiological changes brought on by aging, physiological reactions to microgravity exposure, and non-pharmacological and non-invasive treatment methods that can be used in spaceflight. Sarcopenia, peripheral nerves alteratio...
Source: Journal of Medicine and Life - May 11, 2023 Category: General Medicine Authors: Cosmin Dugan Ioanina Parlatescu Bogdan Ovidiu Popescu Corina Silvia Pop Mihaela Marin Adrian Dinculescu Alexandru Ion Nistorescu Cristian Vizitiu Valentin Nicolae Varlas Source Type: research

A Prospective Intervention to Increase Goals of Care Conversations with Hospitalized Patients Suffering Severe Stroke (Sci204)
1. Through analyzing the process and results of an intervention to increase documented goals-of-care conversations, participants will self-report the ability to apply lessons learned to their clinical practice.2. Participants will self-report the ability to define goals-of-care conversation domains and the ability to demonstrate and integrate these domains within clinical practice.
Source: Journal of Pain and Symptom Management - April 14, 2023 Category: Palliative Care Authors: Amber R. Comer, Shilpee Sinha, Laura Tormoehlen, Lyle Fettig, Stephanie L. Bartlett, Lynn E. D'Cruz, Veronica R. Kassab, Xochitl G. Rivera-Cordova, Leigh Anderson, Lindsay Schroeder, James Slaven, Alexia Torke Source Type: research

Lessons from the Space-2 trial in preventing carotid artery stroke in medically managed patients
The SPACE-2 trial, led by Dr Tilman Reiff1 from Heidelberg University, was a multi-center, randomized, controlled trial including 36 centers in Austria, Germany, and Switzerland. It aimed to directly compare the benefit of intervention vs best medical therapy (BMT) in patients with high-grade asymptomatic carotid artery stenosis. Interventions considered were carotid endarterectomy (CEA) and carotid artery stenting (CAS). Participants were between the ages of 50 and 85  years with at least 70% internal carotid artery stenosis.
Source: Journal of Vascular Surgery - March 7, 2023 Category: Surgery Authors: Young Erben, Thomas G. Brott Source Type: research

The Challenge of Preventing Carotid Artery Stroke in Properly Medically Managed Patients: Lessons From SPACE-2
The SPACE-2 trial led by Dr. Tilman Reiff(1) from Heidelberg University was a multi-center, randomized, controlled trial including 36 centers in Austria, Germany and Switzerland. It aimed to directly compare the benefit of intervention versus best medical therapy (BMT) in high-grade asymptomatic carotid artery stenosis patients. Interventions considered were carotid endarterectomy (CEA) and carotid artery stenting (CAS). Participants were between the ages of 50 and 85 years with at least 70% internal carotid artery stenosis.
Source: Journal of Vascular Surgery - March 7, 2023 Category: Surgery Authors: Young Erben, Thomas G. Brott Source Type: research

Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial
AbstractPurpose of ReviewThe Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) demonstrated the clinical benefit of the combination of ezetimibe-simvastatin compared to placebo-simvastatin following acute coronary syndrome (ACS). This review highlights key findings from this study with particular attention to the practice-changing impact on guidelines for low-density lipoprotein cholesterol (LDL-C) reduction after ACS, especially among high-risk populations.Recent FindingsConsistent reductions in LDL-C have been reported with newer lipid-lowering therapies (proprotein convertase subtilisin/k...
Source: Current Atherosclerosis Reports - February 10, 2023 Category: Cardiology Source Type: research